Crossref
PD-1 inhibitor–associated Sicca syndrome mimicking Sjögren’s disease successfully managed without immunotherapy withdrawal
ARP Rheumatology · 30.09.2026 · 5 (3) · 184-189
DOI: 10.63032/vbwd9327 ↗Kurz gefasst
Fachartikel in der Zeitschrift ARP Rheumatology, online erschienen am 30.09.2026. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). PD-1 inhibitor–associated Sicca syndrome mimicking Sjögren’s disease successfully managed without immunotherapy withdrawal. ARP Rheumatology, 5(3), 184-189. https://doi.org/10.63032/vbwd9327
Vancouver
PD-1 inhibitor–associated Sicca syndrome mimicking Sjögren’s disease successfully managed without immunotherapy withdrawal. ARP Rheumatology. 2026;5(3):184-189. doi:10.63032/vbwd9327
BibTeX
@article{euvimed2026,
title = {PD-1 inhibitor–associated Sicca syndrome mimicking Sjögren’s disease successfully managed without immunotherapy withdrawal},
journal = {ARP Rheumatology},
year = {2026},
volume = {5},
number = {3},
pages = {184--189},
doi = {10.63032/vbwd9327}
}
EUVIMED